TickerFactsScreenerDevelopers

TherapeuticsMD, Inc. (TXMD) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2010: $422.9K2011: $126.4K2023: $4.33M2024: $5.06M$5.06M
2010Cash & Equivalents (USD)2024
Fiscal YearCash & EquivalentsChange YoY
2024$5.06M+16.9%
2023$4.33M—
2011$126.4K-70.1%
2010$422.9K—